Yang Lei, Guo Zhu-Ming, Zeng Zong-Yuan, Chen Fu-Jin, Zhang Quan
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, PR China.
Ai Zheng. 2007 Mar;26(3):325-8.
BACKGROUND & OBJECTIVE: Subglottic cancer is rare. The subglottic region of the larynx is occult, which leads to misdiagnosis or missed diagnosis of subglottic cancer. It is usually advanced when initially presented. There is no large amount case-control study on subglottic cancer, and management of this tumor is still controversial. This study was to analyze the clinical features, treatments, and outcomes of subglottic cancer.
Clinical records of 10 subglottic cancer patients, treated in Cancer Center of Sun Yat-sen University from Jan. 1981 to Oct. 2005, were reviewed.
Of the 10 patients, 4 had intralaryngeal invasion of more than half circle, 4 had extralaryngeal invasion, and 1 had lymph node metastasis. The patients were followed up for 1-15 years; 1 was lost. The overall 5-year survival rate was 55.5% (5/9). Excepted for the 2 patients denied treatment, the 5-year survival rate of the 7 treated patients was 71.4%, the 5-year disease-free survival rate was 42.9%. The 5-year disease-free survival was 0/2 for the patients received radiotherapy alone, 1/2 for those received operation alone, and 2/3 for those received both treatments.
Subglottic cancer is usually advanced when diagnosed, and tends to extend within the larynx and infiltrate other organs. The prognosis is poor. Total laryngectomy is still the main operation for subglottic cancer, and operation combined with radiotherapy is better than single treatment.
声门下癌较为罕见。喉部声门下区域隐匿,这导致声门下癌易被误诊或漏诊。其初诊时通常已属晚期。目前尚无关于声门下癌的大规模病例对照研究,且该肿瘤的治疗仍存在争议。本研究旨在分析声门下癌的临床特征、治疗方法及预后。
回顾性分析1981年1月至2005年10月在中山大学肿瘤防治中心接受治疗的10例声门下癌患者的临床资料。
10例患者中,4例喉内侵犯超过半圈,4例有喉外侵犯,1例有淋巴结转移。患者随访1至15年;1例失访。总体5年生存率为55.5%(5/9)。除2例拒绝治疗外,7例接受治疗患者的5年生存率为71.4%,5年无病生存率为42.9%。单纯接受放疗的患者5年无病生存率为0/2,单纯接受手术的患者为1/2,接受手术联合放疗的患者为2/3。
声门下癌确诊时通常已属晚期,且倾向于在喉内蔓延并侵犯其他器官,预后较差。全喉切除术仍是声门下癌的主要手术方式,手术联合放疗优于单一治疗。